{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-001087","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.999369+00:00","generated_at":"2026-05-28T09:49:31.704605+00:00","sec_items":["5.02","3.02","1.01","3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Cyclacel: $3.1M private placement, CEO resigns, Lazar appointed interim CEO, board revamp, warrant exchange","bullets":["David E. Lazar invests $3.1M for 1M Series C (convertible at 2.65:1) and 2.1M Series D (110:1) preferred shares.","CEO Spiro Rombotis resigns; David Lazar appointed interim CEO; five directors resign, replaced by Natan and Ben-Tzvi.","Company exchanges 24.8M warrants for 24.8M common shares plus $1.1M cash from an institutional holder.","Special meeting by Feb 15, 2025 to vote on stock issuance, reverse split (1:4-1:16), authorized shares to 250M, equity plan increase.","Proceeds used to repay liabilities and for general corporate purposes; cash must support at least three months post-closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-001087","json":"https://secwatch.observer/filing/0001104659-25-001087.json","markdown":"https://secwatch.observer/filing/0001104659-25-001087.md","text":"https://secwatch.observer/filing/0001104659-25-001087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/tm251961d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T09:49:31.704605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"608b3fd629","claim":"David E. Lazar was appointed as interim Chief Executive Officer at Bio Green Med Solution, Inc..","evidence_excerpt":"the Board of Directors appointed Mr. Lazar as interim Chief Executive Officer of the Company, effective as of the signing of the Purchase Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"78cc1b982e","claim":"Christopher Henney resigned as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the \"Resigning Directors\") resigned effective as of the signing of the Purchase Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7cff855175","claim":"Avraham Ben-Tzvi was appointed as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"The Board of Directors also appointed Messrs. David Natan and Avraham Ben-Tzvi as members of the Board of Directors, effective as of the signing of the Purchase Agreement and as of January 5, 2025, respectively.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"85dadf939a","claim":"Kenneth Ferguson resigned as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the \"Resigning Directors\") resigned effective as of the signing of the Purchase Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8f3e9861b7","claim":"Karin Walker resigned as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the \"Resigning Directors\") resigned effective as of the signing of the Purchase Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"af196eb6eb","claim":"David Natan was appointed as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"The Board of Directors also appointed Messrs. David Natan and Avraham Ben-Tzvi as members of the Board of Directors, effective as of the signing of the Purchase Agreement and as of January 5, 2025, respectively.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b94bd576de","claim":"Spiro Rombotis resigned as Chief Executive Officer at Bio Green Med Solution, Inc..","evidence_excerpt":"Mr. Spiro Rombotis resigned as Chief Executive Officer of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"bfe1abcb99","claim":"Robert Spiegel resigned as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the \"Resigning Directors\") resigned effective as of the signing of the Purchase Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f73f3881aa","claim":"Brian Schwartz resigned as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"Dr. Robert Spiegel, Dr. Christopher Henney, Dr. Brian Schwartz, Dr. Kenneth Ferguson and Ms. Karin Walker (together, the \"Resigning Directors\") resigned effective as of the signing of the Purchase Agreement.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}